- Truepill — a company that is driving positive patient experiences through its API-connected healthcare infrastructure — announced that it raised a $25 million Series B funding round
Truepill — a company that is driving positive patient experiences through its API-connected healthcare infrastructure — announced that it raised a $25 million Series B funding round with investments from TI Platform Fund, Optum Ventures, Initialized Capital, Sound Ventures, and several others.
With this round of funding, Truepill will serve the increasing demand from its wide base of customers across the healthcare industry. And the company will continue expanding its product offerings and enriching its integrated direct-to-patient healthcare solutions.
Launched in 2016, Truepill’s unique B2B model builds direct-to-patient experiences across the entire healthcare ecosystem, working with health plans, pharmaceutical manufacturers, and consumer health brands. And Truepill — which is a URAC-accredited company — is transforming traditional healthcare with industry-first API technology, nationwide pharmacy fulfillment and delivery services, a US-based network of licensed telehealth practitioners, white label product design, etc.
Truepill’s technologies and services are built to scale with every customer and its pharmacies have the capacity to deliver 100,000 prescriptions per day. And its US-based network of licensed physicians and nurse practitioners can diagnose and prescribe across 50 states.
Whether a customer is looking to build a direct-to-patient experience from the ground up or simply needs a seamless transparent pharmacy fulfillment partner, there is no other company that offers such an expansive, streamlined solution. Truepill’s customers include GoodRx, TherapeuticsMD, K Health, hims & hers, Nurx, Simple Health and more.
Along with growing its B2B business, Truepill will continue to invest in its portfolio of consumer health brands. Truepill-backed companies include Ahead (a modern mental healthcare startup specializing in adult ADHD treatment) and Eve (a UK-based women’s health company).
“The healthcare industry is facing the most rapid period of change in our lifetime. From consumer healthcare startups to established industry leaders, everyone has been forced to rethink patient care and redesign their business around access and convenience. While COVID-19 has expedited this reality for many companies, Truepill has been building with a patient-first perspective from day one. We’ve created an end-to-end solution that enables our partners to deliver truly accessible and streamlined patient care.”
— Truepill Co-founder and CEO Umar Afridi
“We are working with our partners to deliver the most innovative healthcare experiences for patients. We are excited to see our API-connected infrastructure being leveraged across the entire healthcare ecosystem. We see a future where over 80% of healthcare visits will be performed using telehealth or a digital experience, and we are positioning Truepill to be the platform building that future.”
— Truepill Co-founder and President Sid Viswanathan
“Our team is excited about the impact Truepill can have on the healthcare industry at large. They are powering the future of patient experiences through their industry-first technology and infrastructure, and have the opportunity to advance how consumers engage in their health while helping lower healthcare costs. We are proud to be a part of that journey.”
— Laura Veroneau, Partner at Optum Ventures